<scp>Glucagon‐like peptide</scp> ‐1 receptor agonists in adolescents with overweight or obesity with or without type 2 diabetes multimorbidity—a systematic review and network meta‐analysis
Muhammad Aaqib Shamim(All India Institute of Medical Sciences Jodhpur), Kamlesh Khunti(University of Leicester), Prakasini Satapathy(Chandigarh University), Surjit Singh(Post Graduate Institute of Medical Education and Research), Aravind P. Gandhi(Government Medical College), Santenna Chenchula(All India Institute of Medical Sciences Bhopal), Ashu Rastogi(Post Graduate Institute of Medical Education and Research), Noor Husain(Indira Gandhi Institute of Medical Sciences), Bijaya Kumar Padhi(Post Graduate Institute of Medical Education and Research), Shoban Babu Varthya(All India Institute of Medical Sciences Jodhpur), Venkata Ganesh(Post Graduate Institute of Medical Education and Research), Ulfat Amin(Islamic University of Science and Technology), Amol Patil(Post Graduate Institute of Medical Education and Research), Krishna Raj Tiwari(All India Institute of Medical Sciences Jodhpur), Priyanka Rao(Indian Institute of Public Health Gandhinagar), Ravindra Shukla(All India Institute of Medical Sciences Jodhpur), Tuli Roy(Maharaja Krishna Chandra Gajapati Medical College and Hospital), Jogender Kumar(Post Graduate Institute of Medical Education and Research), Pradeep Dwivedi(All India Institute of Medical Sciences Jodhpur), Ranjit Sah(Dr. D. Y. Patil Medical College, Hospital and Research Centre)
Cited by 18
Related Papers
2. Classification and Diagnosis of Diabetes:<i>Standards of Care in Diabetes—2023</i>
|Diabetes Care|2022|2.4k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k
9. Pharmacologic Approaches to Glycemic Treatment: <i>Standards of Care in Diabetes—2023</i>
|Diabetes Care|2022|850